Engineering HIV-Resistant, Anti-Hiv Chimeric Antigen Receptor T Cells
Molecular Therapy - United States
doi 10.1016/j.ymthe.2016.12.023
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2017
Authors
Publisher
Elsevier BV
Available in full text
March 1, 2017
Elsevier BV